MedPath

Identification of a suitable milk-derived product, the consumption of which could prevent vitamin B12 deficiency (IMPROVIT)

Not Applicable
Completed
Registration Number
CTRI/2017/06/008811
Lead Sponsor
Department of Biotechnology New Delhi India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

Vegetarians with low plasma vitamin B12 in Indian participants

Exclusion Criteria

Non vegetarians, cancer and the participants consuming vitamin B12 pills and the drugs known to influence vitamin B12 absorption

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in homocysteine due to hydroxocobalamin intakeTimepoint: Baseline and every week till eight weeks
Secondary Outcome Measures
NameTimeMethod
Better uptake due to hydroxocobalamin, Increase in holoTC and reduction in HomocysteineTimepoint: Baseline and every week till eight weeks
© Copyright 2025. All Rights Reserved by MedPath